Ithra’s Hijrah: In the Footsteps of the Prophet exhibit revisits the birth of Islam from a modern perspective

DHAHRAN, Saudi Arabia, Aug. 1, 2022 /PRNewswire/ — The King Abdulaziz Center for World Culture (Ithra) is excited to launch Hijrah: In the Footsteps of the Prophet, a research-based artistic retelling of Prophet Mohammad’s  ﷺ journey from Makkah to Madinah. Filling gaps in knowledge on the journey that marked the beginning of the Muslim calendar, the exhibition brings together contemporary and […]

Continue Reading

Vantage partners UNHCR for global fundraising activity for refugees, matches donations dollar-for-dollar.

SINGAPORE, Aug. 1, 2022 /PRNewswire/ — Vantage, an international multi-asset broker, is pleased to announce that it is launching a month-long donation drive in support of UNHCR, the UN Refugee Agency, to help refugees and internally displaced persons worldwide. Vantage will be matching all donations from both new and existing clients, dollar for dollar, to support humanitarian […]

Continue Reading

پناہ گزینوں کے لئے عالمی فنڈ جمع کرنے کی سرگرمی کے لئے وینٹیج کی یو این ایچ سی آر سے شراکتداری، ڈالر کے بدلے ڈالر عطیات سے مطابقت

سنگاپور، 1 اگست 2022 /پی آر نیوز وائر/ – وینٹیج، ایک بین الاقوامی کثیر اثاثہ بروکر، یہ اعلان کرتے ہوئے خوش ہے کہ وہ دنیا بھر میں پناہ گزینوں اور اندرونی طور پر بے گھر افراد کی مدد کے لئے اقوام متحدہ کی پناہ گزین ایجنسی یو این ایچ سی آر کی حمایت میں ایک […]

Continue Reading

AOP Health Starts Research for Leukemia Treatment

AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in the longer term. Agnes Kohl, Chief Business Officer, AOP Orphan Pharmaceuticals GmbH, Member of the […]

Continue Reading

Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease  

WALTHAM, Mass and SHANGHAI, China, July 31, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, announced that it has received approval of its Investigational New Drug (IND) application from the National Medical Products […]

Continue Reading